Drug Profile
Chlorproguanil/dapsone
Alternative Names: Dapsone/chlorproguanil; LAPDAPLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline; World Health Organization
- Class Antimalarials; Biguanides; Sulfones
- Mechanism of Action Antimetabolites; Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Falciparum malaria; Malaria
Most Recent Events
- 08 Dec 2003 Data presented at the 52nd Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH-2003) have been added to the adverse events and Parasitic Infections therapeutic trials section
- 30 Sep 2003 First global launch of LAPDAP™
- 30 Sep 2003 Launched for Falciparum malaria in Africa (PO)